Patents by Inventor Anna Rytter

Anna Rytter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • In vitro ischemia model
    Patent number: 6846641
    Abstract: A tissue culture model of oxygen/glucose deprivation induced cell death is provided, which is useful in the analysis of the mechanisms of cell death following brain ischemia, and for screening anti-ischemic drugs. By adopting the in vivo concentrations of calcium, potassium and hydrogen ions to the incubation medium a model is established that shows conspicuous similarities with the temporal and special development of cell death in vivo: selective and delayed CA1 damage, a damage mitigated by blockade of the NMDA and AMPA receptors, and a striking augmentation of damage by high levels of glucose.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: January 25, 2005
    Assignee: AGY Therapeutics, Inc.
    Inventors: Tadeusz Wieloch, Anna Rytter, Tobias Cronberg
  • In vitro ischemia model
    Publication number: 20030199086
    Abstract: A tissue culture model of oxygen/glucose deprivation induced cell death is provided, which is useful in the analysis of the mechanisms of cell death following brain ischemia, and for screening anti-ischemic drugs. By adopting the in vivo concentrations of calcium, potassium and hydrogen ions to the incubation medium a model is established that shows conspicuous similarities with the temporal and special development of cell death in vivo: selective and delayed CA1 damage, a damage mitigated by blockade of the NMDA and AMPA receptors, and a striking augmentation of damage by high levels of glucose.
    Type: Application
    Filed: April 23, 2002
    Publication date: October 23, 2003
    Inventors: Tadeusz Wieloch, Anna Rytter, Tobias Cronberg